Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus Dalgleish

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
The Lancet. Infectious Diseases|April 28, 2009
Not so SMART?Justin Stebbing, Angus Dalgleish
Advances in Cancer Research|December 13, 2006
Tumor antigens as surrogate markers and targets for therapy and vaccinesAngus Dalgleish, Hardev Pandha
Lancet (London, England)|March 10, 2009
HIV-1 step studyAngus Dalgleish, Justin Stebbing
Expert Review of Anticancer Therapy|July 3, 2004
PreventionAngus Dalgleish, Mike Richards, Karol Sikora
Vaccine|November 2, 2007
Cell based cancer vaccines: regulatory and commercial developmentJohn Copier, Stephen Ward, Angus Dalgleish
Anticancer Research|October 3, 2018
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic CannabidiolJulian Kenyon, Wai Liu, Angus Dalgleish
Immunological Reviews|February 26, 2011
Infection, immunoregulation, and cancerGraham A W Rook, Angus Dalgleish
Molecular Diagnosis & Therapy|December 13, 2006
Biomarkers for the development of cancer vaccines: current statusJohn Copier, Mike Whelan, Angus Dalgleish
Current Opinion in Drug Discovery & Development|February 20, 2008
Technical challenges facing therapeutic cancer vaccinesStephen Ward, John Copier, Angus Dalgleish
Immunotherapy|April 6, 2011
Current status and future applications of cellular therapies for cancerJohn Copier, Mark Bodman-Smith, Angus Dalgleish
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
The Lancet. Infectious Diseases|April 28, 2009
Not so SMART?Justin Stebbing, Angus Dalgleish
Advances in Cancer Research|December 13, 2006
Tumor antigens as surrogate markers and targets for therapy and vaccinesAngus Dalgleish, Hardev Pandha
Lancet (London, England)|March 10, 2009
HIV-1 step studyAngus Dalgleish, Justin Stebbing
Expert Review of Anticancer Therapy|July 3, 2004
PreventionAngus Dalgleish, Mike Richards, Karol Sikora
Vaccine|November 2, 2007
Cell based cancer vaccines: regulatory and commercial developmentJohn Copier, Stephen Ward, Angus Dalgleish
Anticancer Research|October 3, 2018
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic CannabidiolJulian Kenyon, Wai Liu, Angus Dalgleish
Immunological Reviews|February 26, 2011
Infection, immunoregulation, and cancerGraham A W Rook, Angus Dalgleish
Molecular Diagnosis & Therapy|December 13, 2006
Biomarkers for the development of cancer vaccines: current statusJohn Copier, Mike Whelan, Angus Dalgleish
Current Opinion in Drug Discovery & Development|February 20, 2008
Technical challenges facing therapeutic cancer vaccinesStephen Ward, John Copier, Angus Dalgleish
Immunotherapy|April 6, 2011
Current status and future applications of cellular therapies for cancerJohn Copier, Mark Bodman-Smith, Angus Dalgleish
Pageof 5